Also in the Forbes CFO newsletter: How to save money on an overlooked part of M&A, tariffs sour Wall Street and markets, unemployment increases and job losses surge.
The average of price targets set by Wall Street analysts indicates a potential upside of 68.3% in AngioDynamics (ANGO). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Company positions for long-term growth in medical device markets Salt Lake City, UT, April 03, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. ( SINT), an
Operator: Good morning, and welcome to the AngioDynamics Fiscal Year 2025 Third Quarter Earnings Call. At this time, all participants are in a listen-only mode.
Total Revenue: $72 million, representing a growth of over 9% year over year.MedTech Revenue: $31.3 million, a 22.2% increase.Med Device Revenue: $40.7 million,
Apr 02, 2025 / 12:00PM GMTOperator Good morning and welcome to the AngioDynamics fiscal year 20,253 quarter earnings call. (Operator Instructions) As a reminder
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 150 points on Wednesday.
The Dow traded up 0.36% to 42,141.02 while t...
U.S. stocks were lower, with the Dow Jones index falling over 100 points on Wednesday.
Shares of Cognyte Software Ltd. CGNT rose sharply during Wednesday's ses...
Australia-based Innovation Beverage Group Limited (IBG) is up over 192 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular syst
Warren Buffett's Berkshire Hathaway increases stakes in five Japanese trading houses. Forever 21 files for bankruptcy for second time. Joby and Virgin Atlantic to bring flying taxis to UK.
U.S. stock futures were lower this morning, with the Dow futures falling around 0.1% on Thursday.
Shares of UiPath Inc. PATH fell sharply in today's pre-market...
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular syst
Fourth Quarter Highlights” Reported revenue of $355.2 million, up 9.4%Constant currency revenue* and constant currency revenue, organic* up 10.1% and u